PMID: 7020756Jun 9, 1981Paper

Effects of (hydroxymethyl)trimethylpsoralen on structure and function of bacteriophage MS2 ribonucleic acid

Biochemistry
S K Karathanasis, W S Champney

Abstract

Treatment of bacteriophage MS2 with 4'-(hydroxymethyl)-4,5',8-trimethylpsoralen and 360-nm light caused a dose-dependent decline in the infectivity of the virus. Covalent photobinding of a single psoralen molecule on the phage genome was a lethal event. Ribonucleic acid (RNA) extracted from psoralen and light-treated virus had a dose-dependent 385-nm fluorescence emission but was unaltered in its physical properties compared to control RNA samples. Phage adsorption and penetration in Escherichia coli host cells were unaffected, but in vivo replication of the treated virus was affected to the same extent as infectivity. The cell-free translational activity of the MS2 RNA was also severely reduced after psoralen and light treatment of the phage. Examination of the in vitro translation products revealed that the synthesis of the viral replicase protein was most substantially affected. Psoralen treatment of purified, protein-free MS2 RNA promoted an even greater reduction in cell-free synthesis of all viral proteins. This difference in translational function was consistent with the observation that virion-free RNA bound approximately 4 times as much psoralen as did RNA treated within the phage capsid. It was concluded that the repl...Continue Reading

References

Nov 25, 1979·Journal of Molecular Biology·P WollenzienC R Cantor
Nov 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D L OxenderC Yanofsky
Feb 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D SagherS B Weiss
Jun 13, 1979·Biochemical and Biophysical Research Communications·A HirashimaI Watanabe
Apr 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P L WollenzienJ E Hearst
Jul 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·A VandenbergheW Fiers
Feb 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A B Jacobson
Mar 1, 1975·Analytical Chemistry·M H Bothner, D E Robertson
Sep 1, 1975·Virology·W Paranchych, A K Dunker
Jul 1, 1974·European Journal of Biochemistry·W M Bonner, R A Laskey
Sep 1, 1968·Proceedings of the National Academy of Sciences of the United States of America·H P Fromageot, N D Zinder
Jan 1, 1969·The Journal of General Virology·P M Silverman, R C Valentine
Mar 1, 1966·Journal of Molecular Biology·R F Gesteland
Dec 9, 1970·Biochemical and Biophysical Research Communications·R F Gesteland, P F Spahr

❮ Previous
Next ❯

Citations

Sep 1, 1988·Journal of Photochemistry and Photobiology. B, Biology·K TothD Averbeck
May 1, 1983·Photochemistry and Photobiology·M P McKinleyS B Prusiner
May 16, 1983·Biochemical and Biophysical Research Communications·P E Nielsen, W P Linnane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.